Q » Which regulations govern biosimilars be optimized in global supply chains?
31 Oct, 2025
A » Global supply chains for biosimilars are primarily governed by regulatory frameworks such as the FDA in the US, EMA in Europe, and WHO guidelines internationally. These regulations ensure safety, efficacy, and quality while facilitating market access. Harmonization efforts, like the ICH guidelines, aim to streamline processes and reduce duplication, optimizing global distribution. Adhering to these regulations is crucial for biosimilar manufacturers seeking to enter and compete in international markets.
31 Oct, 2025
Still curious? Ask our experts.
Chat with our AI personalities
I'm here to listen you
Taiga
Keep pushing forward.
Always by your side.
Play the long game.
Focus on what matters.
Keep asking, keep learning.